Search

Memorial Sloan Kettering Cancer Center (MSK) announced its recommitment to communities across Long Island today with the dedication of MSK Nassau, a light-filled 114,000-square-foot outpatient cancer treatment facility centrally located along Hempstead Turnpike. MSK’s newest location, and its third on Long Island, will open for patient care on April 8 with more than 180 dedicated medical and professional staff, all of whom are MSK employees.

… Thursday, April 4, 2019 Memorial Sloan Kettering Cancer Center (MSK) announced its recommitment to communities across Long Island today with the dedication of MSK Nassau, a light-filled 114,000-square-foot outpatient cancer treatment facility centrally located along Hempstead Turnpike. MSK’s newest location

We love our smartphones, but could they be harming our health? An MSK expert weighs in.

… Monday, May 20, 2019 Summary A government-funded study published last year raised concerns about the dangers of cell phone radiation. An MSK radiation expert discusses the study’s limitations and weighs in on the evidence related to cell phone use and cancer risk. Back in 1993, a Florida resident named

Read about a new treatment for leptomeningeal metastasis that is giving patients hope.

… Wednesday, January 28, 2026 VIDEO | 03:35 Watch How Two MSK Labs Came Together to Give a Stage 4 Lung Cancer Patient More Time Every cancer breakthrough begins years before it offers patients new hope. Our series Saved by Science takes you inside MSK’s world class research labs, where you’ll see patients

Five Memorial Sloan Kettering scientists have been appointed to a new research team dedicated to identifying targets for therapies to treat a certain form of melanoma.

… Wednesday, December 14, 2011 Summary Five Memorial Sloan Kettering scientists have been appointed to a new research team dedicated to identifying targets for therapies to treat a certain form of melanoma. Stand Up To Cancer (SU2C) has appointed five Memorial Sloan Kettering scientists to its new “Dream

In case you missed it, here’s a recap of Monday’s highlights from the American Society of Clinical Oncology annual meeting.

… Tuesday, June 7, 2016 Summary The challenges of using immunotherapy to treat older patients, an update to an important melanoma clinical trial, and a visit from Vice President Joe Biden were among Monday’s highlights at the American Society of Clinical Oncology (ASCO) annual meeting in Chicago. With

On Thursday, June 18th at 6:00 p.m. E.T. with an encore at 9:00 p.m., MSK will stream a special performance highlighting poignant and humorous perspectives On Cancer and Coronavirus, featuring works from its writing program, Visible Ink.

… Thursday, June 18, 2020 On Thursday, June 18 th at 6:00 p.m. E.T. with an encore at 9:00 p.m. , Memorial Sloan Kettering Cancer Center (MSK) will stream a special performance on visibleink.vimeo.mskcc.org , highlighting poignant and humorous perspectives On Cancer and Coronavirus, featuring works from

An experimental drug for acute myelogenous leukemia might potentially help many more patients than previously thought by controlling epigenetic processes, according to a recent MSK study.

… Friday, January 30, 2015 Summary An experimental drug for acute myelogenous leukemia might potentially help many more patients than previously thought by controlling epigenetic processes, according to a recent MSK study. Epigenetics — the study of biochemical changes that influence a cell’s genetic programming

The MD Anderson Cancer Center presented its annual award to Dr. Scheinberg in recognition of his pioneering work in developing chemotherapeutic agents for leukemia and other cancers.

… Wednesday, June 6, 2012 Summary The MD Anderson Cancer Center presented its annual award to Dr. Scheinberg in recognition of his pioneering work in developing chemotherapeutic agents for leukemia and other cancers. David A. Scheinberg has received the 2012 Emil J. Freireich Award. The award, which is

At Memorial Sloan Kettering Cancer Center’s 43rd annual event recognizing graduates and award winners, honorees were welcomed back to an in-person event.

… Friday, May 20, 2022 GSK dean and graduates in their caps and gowns GSK Dean Michael Overholtzer (center) poses with GSK graduates (from left) Kevin Boehm, Corina Amor Vegas, Jacob Boyer, Amy Shyu, Hsuan-An Chen, and Rui Gao. Line of people in caps and gowns The platform party lines up at the beginning

Memorial Sloan Kettering Cancer Center (MSK) today announced that the New York State Department of Health has issued approval for a new molecular assay, Analysis of Circulating cfDNA to Evaluate Somatic Status (MSK-ACCESS).  MSK-ACCESS was developed within the Marie-Josee and Henry R. Kravis Center for Molecular Oncology (CMO) and the test has been clinically validated and implemented by members of MSK’s Molecular Diagnostics Service.

… Tuesday, June 11, 2019 Memorial Sloan Kettering Cancer Center (MSK) announced that the New York State Department of Health has issued an approval for a new molecular assay called Analysis of Circulating cfDNA to Evaluate Somatic Status (MSK-ACCESS). MSK-ACCESS was developed within the Marie-Josée and